Lantern Pharma Inc (LTRN)

01:09 AM

How Lantern Pharma Inc. stock reacts to oil pricesWeekly Loss Report & Safe Capital Growth Tips - newser.com

01:09 AM

12:33 PM

Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers. - BioSpace

12:33 PM

Oct 28, 2025

Lantern Pharma (NASDAQ: LTRN) Reports Complete Metabolic Response in Phase 1 LP-284 Trial at LL&M Congress - Digital Journal

Oct 28, 2025

Oct 28, 2025

Will Lantern Pharma Inc. stock recover after recent dropWeekly Risk Report & Growth-Oriented Investment Plans - newser.com

Oct 28, 2025

Oct 28, 2025

Using economic indicators to assess Lantern Pharma Inc. potentialIPO Watch & Target Return Focused Picks - newser.com

Oct 28, 2025

Oct 28, 2025

Lantern Pharma (LTRN) Reports Promising Phase 1 Trial Results for LP-284 - GuruFocus

Oct 28, 2025

Oct 28, 2025

Lantern Pharma presents LP-284 clinical data at 25th LL&M Congress - MarketScreener

Oct 28, 2025

Oct 28, 2025

Is Lantern Pharma Inc. stock attractive for income investorsInsider Selling & Weekly Return Optimization Plans - newser.com

Oct 28, 2025

Oct 28, 2025

What technical signals suggest for Lantern Pharma Inc. stockGDP Growth & Growth Focused Stock Pick Reports - Fundação Cultural do Pará

Oct 28, 2025

Oct 28, 2025

Is Lantern Pharma Inc. stock a buy before product launchesTrade Volume Summary & Advanced Technical Analysis Signals - newser.com

Oct 28, 2025

Oct 28, 2025

Lantern Pharma Inc. stock trendline breakdown2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com

Oct 28, 2025

Oct 28, 2025

Will Lantern Pharma Inc. stock maintain dividend yieldQuarterly Trade Summary & Real-Time Sentiment Analysis - newser.com

Oct 28, 2025

Oct 27, 2025

Why Lantern Pharma Inc. stock is favored by pension fundsTrade Exit Summary & Low Risk Profit Maximizing Plans - newser.com

Oct 27, 2025

Oct 27, 2025

Lantern Pharma’s Promising Phase II Lung Cancer Study: Key Insights for Investors - TipRanks

Oct 27, 2025

Oct 27, 2025

Lantern Pharma’s LP-284 Study: A Potential Game-Changer in Cancer Treatment? - TipRanks

Oct 27, 2025

Oct 27, 2025

Lantern Pharma’s LP-184 Study: A Potential Game-Changer in Cancer Treatment - TipRanks

Oct 27, 2025

Oct 27, 2025

When is the best time to exit Lantern Pharma Inc.July 2025 Price Swings & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 27, 2025

Oct 27, 2025

Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025 - BioSpace

Oct 27, 2025

Oct 26, 2025

How to interpret RSI for Lantern Pharma Inc. stock2025 Macro Impact & AI Forecasted Stock Moves - newser.com

Oct 26, 2025